Patents by Inventor Anne Charlotte Arentsen

Anne Charlotte Arentsen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Reduction of the content of protein contaminants in compositions comprising a vitamin K-dependent protein of interest
    Patent number: 9187549
    Abstract: The present invention relates to Vitamin K-dependent protein compositions having a very low, or negligible, content of protein contaminants. The present invention also relates to method applicable in the preparation of such Vitamin K-dependent protein compositions. Such methods may either be used alone or in sequential combination with the purpose of reducing the relative content of protein contaminants. The present invention is particularly relevant in the preparation of compositions of coagulation factors selected from Factor X polypeptides (FX/FXa), Factor IX polypeptides (FIX/FIXa), Factor VII polypeptides (FVII/FVIIa), and the anticoagulant Protein C, in particular Factor VII polypeptides.
    Type: Grant
    Filed: December 23, 2005
    Date of Patent: November 17, 2015
    Assignee: Novo Nordisk Healthcare A/G
    Inventors: Janus Krarup, Thomas Budde Hansen, Anne Charlotte Arentsen, Daniel E. Rasmussen, Are Bogsnes, Arne Staby, Haleh Ahmadian, Susanne Bang
  • Closed container comprising an activated factor VII polypeptide, processes for the preparation of the same, and a kit and a method for use of the kit
    Patent number: 8703706
    Abstract: The present invention relates to a closed container holding a composition of an activated Factor VII polypeptide in an amount of in the range of 2.5-90 mg per imL volume of the container. The invention also relates to various processes for the preparation of such closed containers, a kit including such containers and a method of using the kit.
    Type: Grant
    Filed: April 28, 2006
    Date of Patent: April 22, 2014
    Assignee: Novo Nordisk Healthcare AG
    Inventors: Anne Charlotte Arentsen, Per Kaersgaard
  • Reduction of the Content of Protein Contaminents in Compositions Comprising a Vitamin K-Dependent Protein of Interest
    Publication number: 20080207880
    Abstract: The present invention relates to Vitamin K-dependent protein compositions having a very low, or negligible, content of protein contaminants. The present invention also relates to method applicable in the preparation of such Vitamin K-dependent protein compositions. Such methods may either be used alone or in sequential combination with the purpose of reducing the relative content of protein contaminants. The present invention is particularly relevant in the preparation of compositions of coagulation factors selected from Factor X polypeptides (FX/FXa), Factor IX polypeptides (FIX/FIXa), Factor VII polypeptides (FVII/FVIIa), and the anticoagulant Protein C, in particular Factor VII polypeptides.
    Type: Application
    Filed: December 23, 2005
    Publication date: August 28, 2008
    Applicant: Novo Nordisk HealthCare A/G
    Inventors: Janus Krarup, Thomas Budde Hansen, Anne Charlotte Arentsen, Daniel E. Rasmussen, Are Bognes, Arne Staby, Haleh Ahmadian, Susanne Bang
  • Closed Container Comprising an Activated Factor VII Polypeptide, Processes for the Preparation of the Same, and a Kit and a Method for Use of the Kit
    Publication number: 20080206225
    Abstract: The present invention relates to a closed container holding a composition of an activated Factor VII polypeptide in an amount of in the range of 2.5-90 mg per imL volume of the container. The invention also relates to various processes for the preparation of such closed containers, a kit including such containers and a method of using the kit.
    Type: Application
    Filed: April 28, 2006
    Publication date: August 28, 2008
    Applicant: Novo Nordisk Health Care A/G
    Inventors: Anne Charlotte Arentsen, Per Kaersgaard
  • Crystallization of a GLP-1 analogue
    Patent number: 6844321
    Abstract: Crystals of glucagon-like peptide-1 (GLP-1) and GLP-1 analogues, and processes for preparation of crystals of GLP-1 and GLP-1 analogues.
    Type: Grant
    Filed: January 25, 2001
    Date of Patent: January 18, 2005
    Assignee: Novo Nordisk A/S
    Inventor: Anne Charlotte Arentsen
  • Crystallisation of a GLP-1 analogue
    Publication number: 20030186858
    Abstract: Crystals of glucagon-like peptide-1 (GLP-1) and GLP-1 analogues, and processes for preparation of crystals of GLP-1 and GLP-1 analogues.
    Type: Application
    Filed: January 25, 2001
    Publication date: October 2, 2003
    Inventor: Anne Charlotte Arentsen